Under construction – not a live service
Sign in
CompletedNo phase

The RW-Precision-Coupler Clinical Investigation

Key facts

Who runs it
MED-EL Elektromedizinische Geräte GmbH
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
5 people enrolled
Started
19 May 2021
Ended
26 Nov 2024
Type of study
Interventional
Treatments tested
  • RW-Precision-Coupler
Record updated
3 December 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Geographically and physically able to return to the investigational site for scheduled evaluations and follow-up appointments; Fluent in the German language; Persons of 18 years of age or older; Signed and dated informed consent before the start of any study-specific procedure; The physician must fully assess the potential risks and benefits for the patient prior to the decision to implant the RW-Precision-Coupler. The physician must exercise medical judgment and consider the patient's complete hospital record (also called medical history); No previous active middle ear implant surgery performed in the implanted ear; The following indication for VORP503:; For a patient with sensorineural hearing loss, pure-tone air conduction threshold levels at or within the levels listed below:; For a patient with conductive or mixed hearing loss, pure tone bone-conduction threshold levels at or within the levels listed below:; A patient shall present with an ear anatomy that can facilitate positioning of the FMT in contact with a suitable vibratory structure of the ear; A patient with sensorineural hearing loss shall be a current user of an acoustic hearing aid and have used this aid for at least 4 hours (average) per day for at least 3 months prior to evaluation, or shall not be able to wear or benefit from conventional hearing aids for medical reasons; A patient shall be psychologically and emotionally stable with realistic expectations of the benefits and limitations of the Soundbridge

Who cannot take part

  • Simultaneous participation in another clinical trial (on device or on drug) which would interfere with the results of the study; Pregnancy or lactation; Contraindication for RWP-Coupler Sizer:; if a patient is known to be intolerant of the materials used in the RWP-Coupler; if a patient is known to be intolerant of the materials used in the RWP-Coupler Sizer; in case of a fixed stapes footplate; Contraindication for VORP503:; A patient is known to be intolerant of the materials used in the implant (medical grade silicone elastomer, medical grade epoxy and titanium); A patient with retrocochlear, or central auditory disorders; A patient with nonresponsive active ear infection and/or chronic fluid in or about the ear; A patient whose hearing loss has demonstrated an improving and decreasing fluctuation over a two-year period of 15 dB in either direction; A patient with any physical, psychological, or emotional disorder that would interfere with surgery or the ability to perform on test and rehabilitation procedures; A patient with a skin or scalp condition that may preclude attachment of the audio processor with a magnet

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The RW-Precision-Coupler Clinical Investigation is prospective, non-randomized, open label, single subjects repeated measures, longitudinal monocentric trial. The primary aim of this pre-market clinical investigation is to evaluate the clinical performance and safety of VSB together with the VSB RWP-Coupler in the treatment of hearing loss. As secondary aims are to evaluate the clinical performance of VSB together with RWP-Coupler by measuring Sound Field audiometry (SF), to evaluate the safety of VSB together with RWP-Coupler by measuring bone conduction (BC) thresholds and collecting and assessing adverse events.

The group in the trial

  • Mild to severe hearing lossTreatment being tested

    Treatment: RW-Precision-Coupler

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
3 December 2024